论文部分内容阅读
目的:探讨氨溴索联合阿奇霉素对加快小儿支原体肺炎痊愈速度的影响。方法:选取珠海市平沙医院2013年2月-2014年2月收治的支原体肺炎患儿89例作为研究对象,对其临床资料进行回顾性分析。按照治疗方式划分,对照组43例采用阿奇霉素治疗,观察组46例基于对照组加用氨溴索治疗,对比两组效果。结果:观察组总有效率95.7%,对照组74.7%,差异具有统计学意义(P<0.05);观察组症状或体征消失时间优于对照组(P<0.05);观察组不良反应发生率低于对照组,两组对比差异有统计学意义(P<0.05),观察组疗效优于对照组。结论:氨溴索联合阿奇霉素治疗小儿支原体肺炎效果明显,安全可靠,可加快痊愈速度。
Objective: To investigate the effect of ambroxol and azithromycin on accelerating the recovery rate of mycoplasmal pneumonia in children. Methods: A total of 89 children with Mycoplasmal pneumonia admitted from January 2013 to February 2014 in Pingsha Hospital of Zhuhai City were enrolled in this study. The clinical data were retrospectively analyzed. According to the way of treatment, 43 cases in the control group were treated with azithromycin, and 46 cases in the observation group were treated with ambroxol and the control group. The results were compared between the two groups. Results: The total effective rate was 95.7% in the observation group and 74.7% in the control group, the difference was statistically significant (P <0.05); the disappearance time of symptoms or signs in the observation group was better than that in the control group (P <0.05); the incidence of adverse reactions In the control group, the difference between the two groups was statistically significant (P <0.05), the observation group was better than the control group. Conclusion: Ambroxol combined azithromycin treatment of children with mycoplasma pneumonia is obvious, safe and reliable, can speed up the recovery rate.